Hologic [HOLX] vs Becton, Dickinson [BDX] Detailed Stock Comparison

Hologic

NASDAQ
Loading...

Becton, Dickinson

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Hologic wins in 9 metrics, Becton, Dickinson wins in 10 metrics, with 0 ties. Becton, Dickinson appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricHologicBecton, DickinsonBetter
P/E Ratio (TTM)27.8633.79Hologic
Price-to-Book Ratio3.082.15Becton, Dickinson
Debt-to-Equity Ratio52.0975.93Hologic
PEG Ratio5.781.77Becton, Dickinson
EV/EBITDA12.4712.39Becton, Dickinson
Profit Margin (TTM)13.79%7.41%Hologic
Operating Margin (TTM)25.48%17.81%Hologic
EBITDA Margin (TTM)25.48%17.81%Hologic
Return on Equity11.38%6.18%Hologic
Return on Assets (TTM)6.69%3.96%Hologic
Free Cash Flow (TTM)$1.15B$3.07BBecton, Dickinson
Dividend YieldN/A1.80%N/A
1-Year Return-15.37%-19.57%Hologic
Price-to-Sales Ratio (TTM)3.702.56Becton, Dickinson
Enterprise Value$15.57B$73.31BBecton, Dickinson
EV/Revenue Ratio3.863.43Becton, Dickinson
Gross Profit Margin (TTM)56.32%47.81%Hologic
Revenue per Share (TTM)$18$74Becton, Dickinson
Earnings per Share (Diluted)$2.41$5.65Becton, Dickinson
Beta (Stock Volatility)0.570.28Becton, Dickinson
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Hologic vs Becton, Dickinson Stock Performance Analysis

Loading Price Chart...

Hologic
Becton, Dickinson
Hologic Stock Overview | Becton, Dickinson Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Hologic1.30%3.22%1.95%4.00%12.14%-5.34%
Becton, Dickinson0.35%6.10%1.83%8.08%-15.38%-15.40%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Hologic-15.37%6.51%-2.13%82.16%322.59%379.59%
Becton, Dickinson-19.57%-13.95%-17.24%42.56%162.72%278.88%

News Based Sentiment: Hologic vs Becton, Dickinson

Hologic

News based Sentiment: NEUTRAL

The month's news for Hologic paints a picture of stability rather than dramatic growth. While the stock outperformed the S&P 500 slightly and analyst estimates are trending upward, the overall sentiment is neutral due to the 'Hold' rating and modest gains. The valuation metrics suggest potential value, but don't indicate a strong buy signal.

View Hologic News Sentiment Analysis

Becton, Dickinson

News based Sentiment: POSITIVE

Becton Dickinson had a strong month driven by a significant earnings beat, upward guidance revision, and a strategic partnership focused on the growing pharmacy automation market. While insider selling exists, the overall narrative is positive, supported by high institutional ownership and positive analyst coverage.

View Becton, Dickinson News Sentiment Analysis

Performance & Financial Health Analysis: Hologic vs Becton, Dickinson

MetricHOLXBDX
Market Information
Market Cap i$14.94B$55.66B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i3,267,2601,583,890
90 Day Avg. Volume i2,018,7871,641,000
Last Close$67.91$191.60
52 Week Range$51.90 - $84.39$163.33 - $251.99
% from 52W High-19.53%-23.97%
All-Time High$87.88 (May 01, 2023)$287.32 (Jul 24, 2023)
% from All-Time High-22.72%-33.31%
Growth Metrics
Quarterly Revenue Growth0.01%0.10%
Quarterly Earnings Growth0.00%0.18%
Financial Health
Profit Margin (TTM) i0.14%0.07%
Operating Margin (TTM) i0.25%0.18%
Return on Equity (TTM) i0.11%0.06%
Debt to Equity (MRQ) i52.0975.93
Cash & Liquidity
Book Value per Share (MRQ)$21.79$88.87
Cash per Share (MRQ)$8.47$2.64
Operating Cash Flow (TTM) i$1.07B$3.25B
Levered Free Cash Flow (TTM) i$760.11M$3.37B
Dividends
Last 12-Month Dividend Yield iN/A1.80%
Last 12-Month Dividend iN/A$3.03

Valuation & Enterprise Metrics Analysis: Hologic vs Becton, Dickinson

MetricHOLXBDX
Price Ratios
P/E Ratio (TTM) i27.8633.79
Forward P/E i14.2312.14
PEG Ratio i5.781.77
Price to Sales (TTM) i3.702.56
Price to Book (MRQ) i3.082.15
Market Capitalization
Market Capitalization i$14.94B$55.66B
Enterprise Value i$15.57B$73.31B
Enterprise Value Metrics
Enterprise to Revenue i3.863.43
Enterprise to EBITDA i12.4712.39
Risk & Other Metrics
Beta i0.570.28
Book Value per Share (MRQ) i$21.79$88.87

Financial Statements Comparison: Hologic vs Becton, Dickinson

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)HOLXBDX
Revenue/Sales i$1.01B$5.27B
Cost of Goods Sold i$628.00M$3.02B
Gross Profit i$377.30M$2.26B
Research & Development i$61.50M$302.00M
Operating Income (EBIT) i$37.90M$637.00M
EBITDA i$121.70M$1.21B
Pre-Tax Income i$-28.50M$363.00M
Income Tax i$-11.10M$55.00M
Net Income (Profit) i$-17.40M$308.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)HOLXBDX
Cash & Equivalents i$1.43B$667.00M
Total Current Assets i$3.21B$8.67B
Total Current Liabilities i$989.70M$7.69B
Long-Term Debt i$2.47B$17.67B
Total Shareholders Equity i$4.62B$25.24B
Retained Earnings i$3.03B$16.15B
Property, Plant & Equipment i$939.80MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)HOLXBDX
Operating Cash Flow i$28.40M$941.00M
Capital Expenditures i$-24.70MN/A
Free Cash Flow i$129.20M$35.00M
Debt Repayment i$-10.20M$-1.00M
Common Stock Repurchase i$-200.00M$0

Short Interest & Institutional Ownership Analysis

MetricHOLXBDX
Shares Short i3.11M4.28M
Short Ratio i2.032.41
Short % of Float i0.02%0.02%
Average Daily Volume (10 Day) i3,267,2601,583,890
Average Daily Volume (90 Day) i2,018,7871,641,000
Shares Outstanding i231.73M289.10M
Float Shares i220.32M286.00M
% Held by Insiders i0.01%0.01%
% Held by Institutions i1.01%0.92%

Dividend Analysis & Yield Comparison: Hologic vs Becton, Dickinson

MetricHOLXBDX
Last 12-Month Dividend iN/A$3.03
Last 12-Month Dividend Yield iN/A1.80%
3-Year Avg Annual Dividend iN/A$3.16
3-Year Avg Dividend Yield iN/A0.40%
3-Year Total Dividends iN/A$9.48
Ex-Dividend DateN/AMar 10, 2025